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Abstract
Malignant pleural mesothelioma (MPM) is a fatal tumor. It is often hard to discriminate MPM from metastatic tumors of
other types because currently, there are no reliable immunopathological markers for MPM. MPM is differentially diagnosed
by some immunohistochemical tests on pathology specimens. In the present study, we investigated the expression of
intelectin-1, a new mesothelioma marker, in normal tissues in the whole body and in many cancers, including MPM, by
immunohistochemical analysis. We found that in normal tissues, human intelectin-1 was mainly secreted from
gastrointestinal goblet cells along with mucus into the intestinal lumen, and it was also expressed, to a lesser extent, in
mesothelial cells and urinary epithelial cells. Eighty-eight percent of epithelioid-type MPMs expressed intelectin-1, whereas
sarcomatoid-type MPMs, biphasic MPMs, and poorly differentiated MPMs were rarely positive for intelectin-1. Intelectin-1
was not expressed in other cancers, except in mucus-producing adenocarcinoma. These results suggest that intelectin-1 is a
better marker for epithelioid-type MPM than other mesothelioma markers because of its specificity and the simplicity of
pathological assessment. Pleural intelectin-1 could be a useful diagnostic marker for MPM with applications in
histopathological identification of MPM.
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Introduction
Malignant pleural mesothelioma (MPM) is a fatal tumor. The
median survival of patients with MPM after chemotherapy or
radical surgery is only 9–12 months [1]. Since MPM is correlated
with prior exposure to asbestos [2], the number of people with
MPM is increasing relative to the amount of asbestos used in the
world [3,4]. It is often difficult to diagnose MPM and to distinguish
it from metastatic carcinomas because a sensitive and reliable
diagnostic marker for MPM has not been found yet. The
differential diagnosis of MPM depends on some immunohisto-
chemical tests of surgical pathology specimens. Calretinin,
cytokeratin 5/6 (CK5/6), mesothelin, Wilm’s tumor gene product
1 (WT-1), and podoplanin, often referred to as D2-40, have been
reported as immunohistochemical markers for epithelioid-type
MPM [5–7]. Recently, we reported that a large amount of
intelectin-1 is secreted into the malignant pleural fluid from
epithelioid-type MPMs [8].
The intelectin gene was shown to be specifically expressed in cells
of the small intestine [9]. Intelectin binds to galactofuranosyl
residues and pathogens [10,11], and infection or inflammation
causes an increase in the expression of intelectin mRNA in the
intestine [12,13] or bronchus [14]. Human intelectin-1 is expressed
in intestinal goblet cells, besides in MPMs, and is present at about
200 ng/mL in serum [8]. Intelectin-1 was also shown to be
expressed in human endothelial cells [15] and adipocytes of human
abdominal adipose tissue [16]. However, intelectin-1 expression in
normal or cancerous tissues in humans has not been investigated yet
with human intelectin-1-specific antibodies.
In the present study, we analyzed intelectin-1 expression in
human tissues lacking evident pathological lesions, and in some
cancerous tissues, by immunohistochemical analysis using a
monoclonal antibody against human intelectin-1. Intelectin-1
was expressed in gastrointestinal goblet cells, kidney collecting
tubule cells, some bladder umbrella cells, and some mesothelial
cells. Almost all epithelial-type MPMs (23/26) expressed intelectin-
1, as well as other MPM markers. On the other hand,
sarcomatoid-type MPMs, biphasic MPMs, and poorly differenti-
ated MPMs rarely stained positive with anti-intelectin-1. Intelec-
tin-1 was not expressed in the other cancers, except in some
mucus-producing adenocarcinomas. Mucus-producing metastatic
cancer is rare in the pleura, and it is easy to discriminate between
mucus-producing adenocarcinomas and MPMs in the pleura,
histopathologically. Thus, these results suggested that pleural
intelectin-1 could be a useful diagnostic marker in the histopath-
ological evaluation of MPM.
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All experimental protocols were approved by the ethics
committees of the Kanagawa Cancer Center. Written informed
consent for this study was obtained from each patient. The written
consent for the patient anatomized after death was obtained from
the next of kin or guardian of the patient. All data were analyzed
anonymously throughout the study.
Tissues
We obtained tissue samples of the cholecyst and breast from
patients surgically treated at the Kanagawa Cancer Center
between 2006 and 2010. Other non-tumorous tissue samples were
obtained from patient specimens that were anatomized within 4 h
after death at the Kanagawa Cancer Center between 2006 and
2010. Mesothelioma samples were obtained from patients who
were diagnosed with malignant mesothelioma at the Kanagawa
Cancer Center or Yokohama Municipal Citizen’s Hospital
between 1998 and 2011. Other cancer tissues were obtained from
the primary tumors of the patients who were pathologically
diagnosed as having cancer at the Kanagawa Cancer Center
between 1999 and 2012. The pathology specimens used included
the following cancers: biphasic synovial sarcoma, breast cancer,
colon adenocarcinoma, epithelioid angiosarcoma, epithelioid
hemangioendothelioma, gastric adenocarcinoma, lung cancer,
ovarian adenocarcinoma, renal cell carcinoma, and urothelial
carcinoma.
Normal tissues, which did not have evident pathological lesions,
were extracted from organs at an average time of 8 d after
formalin fixation. The cancer tissues were prepared from formalin-
fixed samples. All specimens were prepared as paraffin-embedded
thin-sliced sections. The specimens, except the mesotheliomas,
were used as tissue microarrays, with the tissue samples cut to a
circle 1 or 3 mm in diameter.
Immunohistochemistry
The sections on glass slides were deparaffinized and rehydrated
with xylene and ethanol and then heated at 95uC for 40 min
(intelectin-1, calretinin, CK5/6, mesothelin, podoplanin, and S-
100 protein) or 121uC for 10 min (WT-1) in an antigen-retrieval
buffer (10 mM Tris buffer [pH 9.0] containing 1 mM ethylene-
diaminetetraacetic acid [intelectin-1, CK5/6, podoplanin, S-100
protein, and WT-1], or 10 mM citrate buffer [pH 6.0] containing
0.1% Tween-20 [calretinin and mesothelin]). Endogenous perox-
idase activity was eliminated by incubating the sections with 3%
hydrogen peroxide for 5 min. After washing the sections with
phosphate-buffered saline, the sections were treated with primary
antibodies for 1 h. They were then washed with 20 mM Tris-
buffered saline (pH 7.6) containing 0.05% Tween 20, and
immunoreactivity was visualized by using Histofine Simple Stain
MAX-PO (Multi) (Nichirei Co., Tokyo, Japan) with the Liquid
DAB+ (Dako Japan Co., Ltd., Kyoto, Japan) or the EnVision+ kits
(Dako Japan Co., Ltd.) according to the manufacturer’s instruc-
tions. The sections were finally counterstained with hematoxylin,
dehydrated, and mounted with Malinol medium (Muto Pure
Chemicals Co., Ltd., Tokyo, Japan). The primary antibodies used
were as follows: intelectin-1, mouse anti-human intelectin-1
monoclonal antibody (3G9) (Immuno-Biological Laboratories
Co., Ltd., Gunma, Japan); calretinin, rabbit anti-calretinin
polyclonal antibody (PAD:DC8) (Life Technologies Japan Ltd.,
Tokyo, Japan); CK5/6, mouse anti-cytokeratin 5,6 monoclonal
antibody (D5/16B4) (Dako Japan Co., Ltd.); mesothelin, mouse
anti-human mesothelin monoclonal antibody (5B2) (Leica Micro-
systems, Inc., Bannockburn, IL); podoplanin, mouse anti-podo-
planin monoclonal antibody (D2-40) (Nichirei Co.); S-100 protein,
mouse anti-S-100 protein monoclonal antibody (4C4.9) (Ventana
Medical Systems, Inc., Tucson, AZ); WT-1, mouse anti-human
WT-1 monoclonal antibody (6F-H2) (Dako Japan Co., Ltd.). Each
antibody was used according to the respective manufacturer’s
instructions.
Immunostaining was evaluated on the basis of the intensity and
proportion of staining on all cancer cells in each specimen. For
evaluating the immunostaining for calretinin or WT-1, the
staining in the nucleus, but not the cytoplasm, was measured.
The intensity of staining was defined by applying the Allred
scoring [17] as follows: 3+, strong staining; 2+, moderate staining;
1+, weak staining; –, no staining. The proportion of staining was
measured in the entire microscopic field of cancer cells for each
specimen and was classified by applying the Allred scoring as
follows: 5, .66%; 4, 66–33%; 3, 33–10%; 2, 10–1%; 1, ,1%; 0,
0%. Cases were defined as positive if the Allred score of the
marker, which is the value of the intensity score plus the
proportion score, was more than 3.
Results
Intelectin-1 Expression in Normal Tissues
Intelectin-1 expression in normal tissues was investigated by
immunohistochemical analysis using an anti-intelectin-1 mono-
clonal antibody. The results are summarized in Table 1.
Intelectin-1 was produced by goblet cells in the duodenum
(Figure 1A), the small intestine (Figure 1B), and the colon
(Figure 1C), but not normal gastric tissue (Figure 1D).
Intelectin-1 was also expressed in goblet cells in intestinal
metaplasia in the stomach. The goblet cells produced intelectin-
1 in complete and incomplete intestinal metaplasias (Figure 1E
and 1F). Paneth cells in the small intestine (Figure 1B, arrow),
the colon (Figure 1C, arrow), and complete intestinal metaplasia
(Figure 1G and 1H, arrows) did not express intelectin-1.
Intelectin-1 was pooled in mucous granules in goblet cells
(Figure 1I) and was secreted with mucus into the intestinal
lumen (Figure 1J). The mucus was not stained with negative
control antibody (Figure S1). Bile duct in the liver (Figure 1K,
open arrow), pancreatic duct in the pancreas (Figure 1L, open
arrows), and other tested components of the digestive system did
not express intelectin-1 (Table 1).
In the urinary system, intelectin-1 was weakly expressed in the
collecting tubule cells in the kidney (Figure 2A, arrow) but was
detected neither in the glomerulus nor in other kidney cells
(Figure 2B). Although almost all cells in the bladder were
intelectin-1-negative (Figure 2C), a donor exhibited intelectin-1
expression in umbrella cells in the bladder (Figure 2D, arrow).
Bronchial epithelium including goblet cells (Figure 2E), serous
glands (Figure 2E and 2F, open arrows), and lung (Figure 2G)
did not express intelectin-1. On the other hand, mucous cells in
the bronchial mucous gland (Figure 2F, closed arrow) and
mesothelial cells in the pleura (Figure 2H), peritoneum (Figure 2I),
tunica vaginalis (Figure 2J), or pericardium (Figure 2K) often
expressed intelectin-1. Intelectin-1 expression was not observed in
cardiac muscle, endocardium (Figure 2L), or vascular endothelial
cells (Figure 2M). S-100 protein, which is expressed in adipocytes
[18], was detected in the cytoplasm of adipocytes in abdominal
adipose tissue (Figure 2N), whereas intelectin-1 was not detected
in adipocytes (Figure 2O). Intelectin-1 expression was observed in
the mesothelial cells on adipose tissue rather than in adipocytes
(Figure 2P, arrow). Adrenal cortex was weakly stained with anti-
intelectin-1 (Table 1). Intelectin-1 was not expressed in other
tested tissues, including endocrine organs, muscle tissue, skin,
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Organ
Intensity of intelectin-1 staining
(No. of score/No. of samples) Positive cell
3+ 2+ 1+ –
Digestive system Tongue 1/1
Esophagus 2/2
Stomach (normal tissue) 3/3
Stomach (IM) 9/9 Goblet cells
Duodenum 2/2 Goblet cells
Small intestine 4/4 Goblet cells
Colon 9/9 Goblet cells
Appendix 2/2
Liver 8/8
Pancreas 11/11
Cholecyst 6/6
Urinary system Bladder 1/4 3/4 Umbrella cells
Kidney 6/10 4/10 Collecting tubule cells
Ureter 1/1
Mesothelium Pleura 3/10 7/10 Mesothelial cells
Peritoneum 1/2 1/2 Mesothelial cells
Tunica vaginalis 1/2 1/2 Mesothelial cells
Pericardium 1/1 Mesothelial cells
Endocrine organ Pituitary gland 5/5
Adrenal 3/5 2/5 Cortex cells
Thyroid 9/9
Parathyroid 3/3
Adipose tissue* 5/5
Greater omentum 1/2 1/2 Mesothelial cells
Vascular Aorta 3/3
Vascular endothelium* 5/5
Nervous system White substance 13/13
Gray substance 16/16
Ventricle 4/4
Basal nucleus 2/2
Nigra 2/2
Cerebellum 1/1
Spinal cord 1/1
Dura mater 1/1
Nerve plexus 1/1
Respiratory system Bronchus 5/15 10/15 Bronchial mucous gland
Lung 36/36
Diaphragm 2/2
Lymphoid system Lymph node 6/6
Thymus gland 3/3
Spleen 3/3
Bone marrow 7/7
Reproductive system Breast 6/6
Ovary 4/4
Uterus 4/4
Vaginal 1/1
Testis 6/6
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Organ
Intensity of intelectin-1 staining
(No. of score/No. of samples) Positive cell
3+ 2+ 1+ –
Prostate 11/11
Muscle tissue Skeletal muscle 1/1
Smooth muscle 3/3
Cardiac muscle 19/19
Skin Epidermis 1/1
Bone Spondylus 7/7
Expression scores were assigned by evaluating the intensity of intelectin-1 staining on the positive cells. The intensity of staining was defined by applying the Allred
scoring as follows: 3+, strong staining; 2+, moderate staining; 1+, weak staining; –, no staining. The asterisk indicates the tissue in the digestive, urinary, respiratory, or
reproductive system. IM, intestinal metaplasia.
doi:10.1371/journal.pone.0039889.t001
Figure 1. Expression of intelectin-1 in gastrointestinal goblet cells. Specimens were immunostained with anti-intelectin-1, and
representative photographs are shown here. The scale bar (100 mm) is shown at the bottom of panel A, representatively. The scale bars of panel G
(100 mm), panel H (100 mm), panel I (50 mm), and panel J (50 mm) are also shown. The arrows indicate paneth cells. A, duodenum; B, small intestine;
C, colon; D, stomach; E, complete intestinal metaplasia (IM) in stomach; F, incomplete IM in stomach; G, hematoxylin–eosin (HE) staining of complete
IM in stomach; H, complete IM in stomach; I, mucous granules in goblet cells; J, mucus-secreting goblet cells; K, liver and bile duct (open arrow); L,
pancreas and pancreatic duct (open arrows).
doi:10.1371/journal.pone.0039889.g001
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systems (Table 1).
These results suggest that intelectin-1 is mainly secreted from
intestinal goblet cells along with mucus into the intestinal lumen
and that mesothelial cells and epithelial cells in the urinary system
produce intelectin-1 only occasionally, in response to some
stimulatory signals.
Intelectin-1 Expression in Mesotheliomas
Epithelioid-type MPMs were immunostained with antibodies
against intelectin-1 or typical mesothelioma markers, such as
calretinin, CK5/6, podoplanin, WT-1, and mesothelin. Repre-
sentative images of immunostaining against these antigens are
shown in Figure 3. The results are summarized in Table 2, and
the individual data are shown in Table S1. Eighty-eight percent
Figure 2. Expression of intelectin-1 in normal tissues. Specimens were immunostained with anti-intelectin-1, and representative photographs
are shown. A scale bar (100 mm) is shown in panel A, representatively. The scale bars of panel G (100 mm) and panel P (100 mm) are also shown. The
closed black arrows indicate intelectin-1-positive cells. A, kidney collecting tubule; B, kidney cortex; C, intelectin-1-negative bladder; D, intelectin-1-
positive bladder; E, bronchus. The open arrow shows the serous gland; F, bronchus. The open or closed arrow shows the serous or mucous gland,
respectively; G, lung; H, intelectin-1-positive pleura; I, intelectin-1-positive peritoneum; J, intelectin-1-positive tunica vaginalis; K, pericardium; L,
cardiac muscle and endocardium; M, vascular; N, S-100 protein staining of adipocytes in greater omentum; O, adipocytes in greater omentum; P,
greater omentum with mesothelial cells.
doi:10.1371/journal.pone.0039889.g002
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with anti-intelectin-1 (Table 2). As shown in Figure 3, intelectin-
1 and CK5/6 were detected in the cytoplasm. Both the
cytoplasm and the nucleus stained positive for calretinin and
WT-1, but the staining in the nucleus was important for
distinction of MPM cells. Podoplanin and mesothelin were
mainly present on the cell membrane. The average Allred score
of intelectin-1 (5.8) in epithelioid-type MPM was similar to that
of calretinin (6.0), CK5/6 (6.2), podoplanin (5.5), WT-1 (5.9),
and mesothelin (5.7) (Table 2). The proportion of intelectin-1-
positive cells in epithelioid-type MPMs was higher than that of
other markers (Table S1). Sarcomatoid-type MPMs, poorly
differentiated MPMs, or biphasic MPMs were rarely stained
with anti-intelectin-1 (Table 2). These results suggest that
Figure 3. Immunostaining of mesothelioma markers in MPM. A scale bar (50 mm) is shown at the bottom right. The patient ID (Table S1) is
shown at the upper left on each panel.
doi:10.1371/journal.pone.0039889.g003
Table 2. Expression of marker antigens in MPM.
MPM type Intelectin-1 Calretinin CK5/6 Podoplanin WT-1 Mesothelin
Epithelioid 23/26 26/26 24/26 23/26 23/26 25/26
Allred score 0201220
2000000
3101111
4332106
5262534
6353856
7 1 11 11 49 1 48
8413011
Average 5.8 6.0 6.2 5.5 5.9 5.7
PD 1/3 1/3 3/3 2/3 2/3 2/3
Biphasic 1/3 3/3 3/3 2/3 2/3 1/3
Sarcomatoid 0/7 0/7 2/7 4/7 5/7 0/7
The histologic type of MPM was classified by pathological diagnosis. The intensity and proportion of staining of MPM cells were evaluated in the entire microscopic field
of the specimen. The individual data are described in Table S1. Cases were defined as positive if the Allred score, which is the value of the intensity score plus the
proportion score, of the marker was more than 3. In the immunostaining of calretinin or WT-1, staining in the nucleus, but not the cytoplasm, was designated as a
positive sample. PD, poorly differentiated.
doi:10.1371/journal.pone.0039889.t002
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of epithelioid-type MPMs.
Insignificant Expression of Intelectin-1 in Other Cancers
To investigate intelectin-1 expression in cancers that may be
confused with MPM in histopathological analyses, we prepared
tissue microarrays of several primary tumors: biphasic synovial
sarcoma, breast cancer, colon adenocarcinoma, epithelioid angio-
sarcoma, epithelioid hemangioendothelioma, gastric adenocarci-
noma, lung cancer, ovarian adenocarcinoma, renal cell carcino-
ma, and urothelial carcinoma. As shown in Figure 4 and Table 3,
intelectin-1 was not expressed significantly in these cancers, except
for some mucus-producing adenocarcinomas (Figure 4B, 4D, and
Table 3, marked with an asterisk). The differential diagnosis
between lung cancer and MPM is often a serious problem.
Intelectin-1 was expressed in only 1 of 88 cases of lung cancer,
whereas calretinin, CK 5/6, podoplanin, and mesothelin were
expressed in about 23%, 44%, 14%, and 40% of lung cancers,
respectively (Table 3). Representative images of intelectin-1 and
calretinin staining of lung cancer are shown in Figure 4E–H.
Calretinin, CK 5/6, podoplanin, or mesothelin was often
expressed in other cancers (Table 3). The nuclear staining for
WT-1 was specifically observed in MPM (Table 3), but 64% of
other cancers stained for WT-1 in the cytoplasm. Furthermore, the
cytoplasm of normal cells was often strongly stained for WT-1 in
many tissues (data not shown). Because of the cytoplasmic staining
for WT-1, the nuclear staining for WT-1 could not be
distinguished very clearly.
Histopathologically, it would be easy to distinguish the mucus-
producing adenocarcinoma, which expressed intelectin-1, from
MPM on pleura. Therefore, these results suggest that intelectin-1
staining is an excellent histopathological tool for differentiating
epithelioid-type MPMs from other cancers.
Discussion
Utility of Intelectin-1 Staining in Differential Diagnosis of
MPM
It is difficult to distinguish MPM from metastatic tumors of
other cancers. Pleura-invading lung adenocarcinoma cells, in
particular, resemble epithelioid-type MPM cells in histopathology.
Further, during immunohistological diagnosis, these cells are likely
to be confused for each other because they often express the same
antigens. CK5/6 and mesothelin are often expressed in lung and
other cancers. Even calretinin, which is a typical MPM marker,
was shown to be expressed in about 20% of lung adenocarcinomas
(Table 2) [6]. In this study, we found that intelectin-1 is expressed
by about 90% (23/26 cases) of epithelioid-type MPMs and by
,5% (1/68 cases) of lung adenocarcinomas. Other cancers, except
mucus-producing adenocarcinomas, were not stained significantly
with anti-intelectin-1. The achromatic ratio of intelectin-1 in non-
MPM tumors was better than that of other MPM markers. Mucus-
producing metastatic cancer is rare in the pleura, and it is easy to
discriminate between mucus-producing cancers and MPMs in the
pleura. Thus, intelectin-1 staining would be useful in the
differential diagnosis of epithelioid-type MPMs from other
cancers.
Intelectin-1 staining is an excellent means of performing a
differential diagnosis of MPM, not only due to its specificity for
MPM but also due to the evidently higher positive proportion of
MPMs (Table S1). The higher positive proportion could be useful
for detection of MPM in a small biopsy-resected tissue. In
addition, intelectin-1 staining is easy to observe in specimens
because intelectin-1 expression is not detectable in most cells in
normal tissues. Although podoplanin was a good marker of MPM
with regard to specificity (Table 2 and 3), the staining of some
stromal cells in tissues often interfered with podoplanin detection
of MPMs (data not shown). Similarly, nuclear staining for WT-1
was specifically observed in MPMs (Tables 2 and 3) [5]; however,
its use in differential diagnosis is likely to be limited because the
antigen is often and strongly detected in the cytoplasm of various
cancer cells and normal cells (data not shown). The simplicity of
assessment using intelectin-1 staining ensures better differential
diagnosis than when other mesothelioma markers are used.
Therefore, intelectin-1 staining could be useful in diagnosing
epithelioid-type MPMs, which account for 50–80% of MPMs, in
cases suspected to be mesothelioma.
There were no non-MPM tumors, which were positive for both
intelectin-1 and calretinin. In brief, epithelioid-type MPM could
be distinguished from all tested cancers (n=201) by double
positive staining of intelectin-1 and calretinin at 88% of sensitivity
and 100% of specificity. Non-epithelioid MPM expressed little
intelectin-1, therefore intelectin-1 staining would be unable to
replace all other MPM markers as a diagnostic marker for MPM.
However, the complementary staining of intelectin-1 and
calretinin could help diagnose epithelioid-type MPM. Further-
more, immunostaining of podoplanin and WT-1 would be useful
for diagnosis of sarcomatoid-type MPM. The expression of these
markers in metastatic tumor into the pleura is not well
characterized. Further investigation is needed for designing a
staining panel for pleural tumors using histological diagnostic
markers, like cytokeratin and mucin antigen.
Intelectin-1 Expression in Normal Tissues
Intelectin-1 was expressed mainly in the intestine. Mouse
intelectin was reported to be expressed in intestinal paneth cells
[9]. However, human intelectin-1 was pooled in mucous granules
in goblet cells, but not in paneth cells. Although human intelectin-
1/lactoferrin receptor has been reported to be a glycopho-
sphatidylinositol-anchored membrane protein [19], intelectin-1
was obviously secreted along with mucus into the intestinal lumen
(Figure 1, panel J) and was present as a soluble protein in mucus,
adhering to microvilli rather than as a membrane-anchored
protein. Human intelectin-1 could be a soluble protein secreted
from intestinal goblet cells along with mucus.
Intelectin-1 was found to be expressed in the airway upon
inflammation of the respiratory system [14]. In our study,
intelectin-1 was occasionally detected in normal bronchial mucous
gland, but not in goblet cells, ciliated cells, or serous cells in normal
bronchus (Figure 2E and 2F). Inflammation of bronchi causes
hyperplasia of goblet cells and an increase in the production of
mucus containing MUC2 [20]. Intestinal goblet cells secrete
MUC2 [21] and intelectin-1. Thus, the bronchial intelectin-1 may
be expressed in MUC2-producing goblet cells in the bronchus in
addition to the bronchial mucous gland.
Neither liver nor pancreas was stained with the monoclonal
antibody against human intelectin-1. In a previous report,
intelectin was detected in liver and pancreas, although polyclonal
antibodies were used in the immunohistochemical studies [22].
Intelectin-1 mRNA has been detected in some organs besides the
intestine, but not in liver and pancreas [10,15]. Thus, the
polyclonal antibodies against intelectin might bind to some
antigens other than intelectin-1, like intelectin-2 [8], in these
tissues.
Although intelectin-1 mRNA had been clearly detected in heart
[10], intelectin-1 protein was expressed in only the mesothelial
cells of the pericardium, but not the cardiac muscle or the
endocardium. Similarly, intelectin-1/omentin was reported to be
Expression of Intelectin-1 in Human Tissues
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intelectin-1 was detected in mesothelial cells on adipose tissue
rather than in adipocytes. The intelectin-1/HL-1 expression in
vascular endothelial cells reported previously [15] was not
confirmed in our results. Furthermore, intelectin-1 was not
secreted from vascular endothelial cells cultured in vitro–human
umbilical vein endothelial cells, unstimulated or stimulated with
interleukin-4 or tumor necrosis factor-alpha (data not shown).
These results suggested that the intelectin-1 expression detected in
the heart or the omentum might have occurred in the mesothelial
cells that covered the organs and that vascular endothelial cells
express little intelectin-1 protein.
Occasional expression of intelectin-1 was observed in mesothe-
lial cells, kidney collecting tubule cells, and umbrella cells in the
bladder, suggesting that intelectin-1 was transiently expressed in
these cells. The intelectin-1 in non-goblet cells, including MPMs,
was diffusely detected in cytoplasm lacking large mucous granules.
Since a viscous secretion with intelectin-1 was often observed in
MPMs and malignant pleural effusions of MPMs contained
intelectin-1 [8], the intelectin-1 in non-goblet cells could be
secreted extracellularly, through the constitutive secretory pathway
without accumulating into secretory vesicles first. The intelectin-1
production in non-goblet cells may be controlled by transcriptional
regulation in a manner different from the one observed in goblet
cells. Analysis of the transcriptional regulation of intelectin-1 in
non-goblet cells may be helpful in identifying the reasons behind
the specific expression of this antigen in MPMs.
Supporting Information
Figure S1 Specific binding of anti-intelectin-1 in mucus.
Specimens with goblet cells were immunostained with anti-
intelectin-1 or a negative control antibody (anti-WT-1 monoclonal
antibody (6F-H2)). The mucus was not stained with the antibody
for the negative control.
(TIF)
Table S1 Intensity and proportion of immunohisto-
chemical staining of MPM against mesothelioma mark-
ers. The intensity of staining was defined by applying the Allred
scoring as follows: 3+, strong staining; 2+, moderate staining; 1+,
weak staining; –, no staining. Representative photographs of
staining are shown in Figure 3. The proportion of staining was
measured for MPM cells in the entire microscopic field of each
specimen. In the immunostaining of calretinin or WT-1, staining
in the nucleus, but not the cytoplasm, was designated as a positive
sample. CK5/6, cytokeratin 5, 6; MPM, malignant pleural
mesothelioma; WT-1, Wilm’s tumor gene product 1.
(PDF)
Figure 4. Insignificant expression of intelectin-1 in non-MPM cancers that lack mucus production. Specimens were immunostained with
MPM markers, and representative photographs are shown. A scale bar (100 mm) is shown in the bottom side of panel A, representatively. A,
intelectin-1 staining of a colon adenocarcinoma (AD) lacking mucus production; B, intelectin-1 staining of mucus-producing colon AD; C, intelectin-1
staining of a gastric AD lacking mucus production; D, intelectin-1 staining of mucus-producing gastric AD; E, intelectin-1 staining of lung AD; F,
calretinin staining of lung AD; G, intelectin-1 staining of lung squamous cell carcinoma (SCC); H, calretinin staining of lung SCC.
doi:10.1371/journal.pone.0039889.g004
Table 3. Expression rate of mesothelioma markers in some cancers.
Cancer (n) Histologic subtype Intelectin-1 Calretinin CK5/6 Podoplanin WT-1 Mesothelin
Lung cancer (88) 1/88 20/88 39/88 12/88 0/88 35/88
AD, acinar (40) 0 9 12 2 0 17
AD, lepidic (2) 0 1 0 0 0 0
AD, micropapillary (6) 0 0 2 1 0 4
AD, papillary (10) 0 2 3 0 0 2
AD, solid (10) 1 1 2 0 0 6
S C C ( 2 0 ) 072 0 906
RCC (10) 0/10 0/10 1/10 0/10 0/10 0/10
UC (10) 1/10 2/10 7/10 0/10 0/10 0/10
Gastric AD (10) 4/10 2/10 7/10 6/10 0/10 1/10
*Mucous (6) 4 0 5 5 0 1
Non-mucous (4) 0 2 2 1 0 0
Colon AD (11) *1/11 1/11 1/11 0/11 0/11 0/11
Breast cancer (10) 0/10 1/10 2/10 0/10 1/10 0/10
Ovarian AD (10) *1/10 0/10 7/10 1/10 3/10 6/10
EHE (6) 0/6 0/6 3/6 2/6 0/6 0/6
EAS (2) 0/2 2/2 2/2 1/2 0/2 0/2
BSS (5) 0/5 4/5 4/5 2/5 0/5 2/5
Intensity and proportion of staining in the cancer cells were evaluated in the entire microscopic field of each specimen. Cases were defined as positive if the Allred score
of the marker was more than 3. In the immunostaining of calretinin or WT-1, staining in the nucleus, but not the cytoplasm, was designated as a positive sample.
Calretinin or WT-1 was detected in the cytoplasm of 14% or 64% of cancers, respectively. The asterisk marks the sample from a mucus-producing cancer. AD,
adenocarcinoma; BSS, biphasic synovial sarcoma; EAS, epithelioid angiosarcoma; EHE, epithelioid hemangioendothelioma; RCC, renal cell carcinoma; SCC, squamous cell
carcinoma; UC, urothelial carcinoma.
doi:10.1371/journal.pone.0039889.t003
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